TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹55 Cr | ₹21 Cr | ₹12 Cr | ₹7.62 Cr |
What is the latest Total Current Liabilities ratio of TRIDENT LIFELINE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹55 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹7.62 Cr |
How is Total Current Liabilities of TRIDENT LIFELINE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹55 Cr | 163.62 | |
| Mar2024 | ₹21 Cr | 76.55 | |
| Mar2023 | ₹12 Cr | 55.64 | |
| Mar2022 | ₹7.62 Cr | - | |
Compare Total Current Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹299.3 Cr | 2.1% | 2.2% | 3.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,997.0 Cr | 4.1% | -1.3% | -7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,900.0 Cr | 3% | 7.7% | 7.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,804.0 Cr | 2.1% | 0.1% | 26.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,389.0 Cr | 9.3% | 6.6% | 12% | Stock Analytics | |
| CIPLA | ₹106,397.0 Cr | 6.8% | 7.7% | -15.3% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 2.1% |
2.2% |
3.1% |
| SENSEX | -1.6% |
3.7% |
-2.7% |
You may also like the below Video Courses